Novak and coworkers demonstrated that adenoviral vectors expressing RYBP inhibited proliferation of tumour cells by inducing apoptosis, either alone or in combination with TNF‐α and etoposide, thus implicating RYBP as a therapeutic target in cancer 42. This evidence concerns the gene RYBP and neoplasm.